• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    T. Rowe Price Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    10/16/25 9:14:45 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance
    Get the next $TROW alert in real time by email
    trow-20251013
    0001113169falsePRICE T ROWE GROUP INC00011131692025-10-132025-10-13

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): October 13, 2025

    T. Rowe Price Group, Inc.
    (Exact name of registrant as specified in its charter)
    Maryland000-3219152-2264646
    (State of
    incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    1307 Point Street, Baltimore, Maryland 21231
    (Address of principal executive offices)(Zip Code)

    Registrant's telephone number, including area code: (410) 345-2000
    ____________________________________
    (Former Name or Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Stock, par value $0.20TROW
    The NASDAQ Stock Market LLC
    (Nasdaq Global Select Market)

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12-2 of this chapter).
                                            Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Section 5 – Corporate Governance and Management

    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On October 13, 2025, the Board of Directors (the “Board”) of T. Rowe Price Group, Inc. (the “Company”) increased the number of directors from 11 to 13, and elected Mr. Allan Golston and Mr. Richard Verma as directors of the Company. Mr. Golston was appointed to the Audit Committee and to the Executive Compensation and Management Development Committee. Mr. Verma was appointed to the Nominating and Corporate Governance Committee and to the Executive Compensation and Management Development Committee.

    The Board determined that each of Messrs. Golston and Verma are an “independent director” in accordance with the NASDAQ Listed Company Rules, the rules and regulations of the Securities and Exchange Commission and the Company’s Corporate Governance Guidelines.

    Mr. Golston is the President of the United States Program at the Gates Foundation, a private foundation that supports initiatives in education, world health and population and community giving, since 2006. Prior to this role, Mr. Golston served as Interim Executive Director of the Global Health Program and as Chief Financial and Administrative Officer for the Gates Foundation from 2005 to 2006 and 2000 to 2006, respectively. Mr. Golston also held previous roles as a finance executive and leading finance divisions with the Swedish Health System and the University of Colorado Hospital and served as an auditor with KPMG from 1989-1991.

    Mr. Golston earned a B.S. in Accounting from the University of Colorado and a M.S. in Business Administration from Seattle University.

    Mr. Golston is a member of the board of directors of Harley Davidson and is the chair of the nominating and corporate governance committee and a member of the audit and finance committee. He also served on the board of directors of Stryker Corporation from January 2011 through May 2025.

    Mr. Verma has been the chief administrative officer for Mastercard Incorporated, an American multinational financial services corporation, overseeing the company’s law, government affairs and policy, franchise, corporate security, and community and belonging functions since 2025. He is also a member of the company’s executive leadership team and management committee. He was the deputy secretary of state for management and resources and acted as chief operating officer of the State Department, from 2023 to 2025. Prior to serving in that position, he was the general counsel and head of global public policy at Mastercard from 2020 to 2023. Mr. Verma previously served as the vice chairman and a partner at The Asia Group, from 2017 to 2020. He served as United States Ambassador to India from 2014 to 2017. Mr. Verma was assistant secretary of state for legislative affairs from 2009 to 2011 and was senior national security advisor to the U.S. Senate majority leader from 2004 to 2007. He also was a partner and senior counselor with Steptoe & Johnson LLP, a global law firm, and is a U.S. Air Force veteran, who served as judge advocate during active duty.

    Mr. Verma holds a doctorate in International Relations from Georgetown University, a law degree, cum laude, from American University, a Masters of Law with distinction in International Law from Georgetown University Law Center, and a Bachelor of Science from Lehigh University.

    He is a board member of the Ford Foundation, and has previously served on the boards for Lehigh University and the National Endowment for Democracy. In addition Mr. Verma served on our board from 2018 to 2023.

    Section 9 - Financial Statements and Exhibits.

    Item 9.01. Financial Statements and Exhibits.

    (d) Exhibits.

    99.1 Press Release dated October 16, 2025




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    T. Rowe Price Group, Inc.
    By: /s/ David Oestreicher
    Vice President, General Counsel and Secretary
    Date: October 16, 2025

    Get the next $TROW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TROW

    DatePrice TargetRatingAnalyst
    10/3/2025$108.00Market Perform
    BMO Capital Markets
    9/12/2024$109.00Equal Weight
    Wells Fargo
    8/27/2024$99.00Underweight
    Barclays
    4/11/2024$106.00 → $120.00Underperform → Mkt Perform
    Keefe Bruyette
    4/8/2024$92.00 → $114.00Sell → Hold
    TD Cowen
    1/8/2024$95.00 → $105.00Equal Weight → Underweight
    Wells Fargo
    1/4/2024$88.00Underperform
    TD Cowen
    10/31/2023$100.00 → $95.00Sell → Neutral
    Citigroup
    More analyst ratings

    $TROW
    SEC Filings

    View All

    T. Rowe Price Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PRICE T ROWE GROUP INC (0001113169) (Filer)

    11/3/25 8:39:52 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 10-Q filed by T. Rowe Price Group Inc.

    10-Q - PRICE T ROWE GROUP INC (0001113169) (Filer)

    10/31/25 1:40:17 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. Rowe Price Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PRICE T ROWE GROUP INC (0001113169) (Filer)

    10/31/25 7:01:49 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Robert W. Sharps was granted 523 shares and gifted 2,500 shares, decreasing direct ownership by 0.36% to 540,529 units (SEC Form 4)

    4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

    11/25/25 9:59:02 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Director Verma Richard R. was granted 2,859 shares (SEC Form 4)

    4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

    10/29/25 12:16:47 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Director Golston Allan C. was granted 2,859 shares (SEC Form 4)

    4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

    10/29/25 12:16:28 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on T. Rowe Price with a new price target

    BMO Capital Markets initiated coverage of T. Rowe Price with a rating of Market Perform and set a new price target of $108.00

    10/3/25 8:45:55 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Wells Fargo initiated coverage on T. Rowe Price with a new price target

    Wells Fargo initiated coverage of T. Rowe Price with a rating of Equal Weight and set a new price target of $109.00

    9/12/24 9:14:34 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Barclays initiated coverage on T. Rowe Price with a new price target

    Barclays initiated coverage of T. Rowe Price with a rating of Underweight and set a new price target of $99.00

    8/27/24 7:37:56 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    T. ROWE PRICE EXPANDS FIXED INCOME OFFERINGS WITH FOUR NEW ACTIVE ETFS

    The T. Rowe Price Short Municipal Income, Long Municipal Income, High Income Municipal and Multi-Sector Income ETFs began trading today, expanding the firm's ETF lineup to 28 BALTIMORE, Nov. 20, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm and leader in retirement, announced today the addition of four new active fixed income exchange-traded funds (ETF): T. Rowe Price Short Municipal Income ETF (Ticker: TMNS), T. Rowe Price Long Municipal Income ETF (Ticker: TMNL), T. Rowe Price High Income Municipal ETF (Ticker: THYM), and the T. Rowe Price Multi-Sector Income ETF (Ticker: TMSF). The new funds began trading on the NASDAQ exchange today. T. Rowe Pr

    11/20/25 10:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE EXPERTS SHARE 2026 OUTLOOK FOR GLOBAL FINANCIAL MARKETS

    Though inflation and high valuations remain a concern, the AI boom combined with monetary and fiscal stimulus in the U.S. and an expansionary phase in Europe appears to set the stage for favorable market conditions in 2026. BALTIMORE, Nov. 19, 2025 /PRNewswire/ -- T. Rowe Price held its 43rd annual global market outlook press briefing today, featuring a panel of the firm's investment experts sharing their forecasts for the 2026 global financial markets. Speakers included Tim Murray, capital markets strategist; Josh Nelson, head of Global Equity; Ken Orchard, head of International Fixed Income; Sébastien Page, head of Global Multi-Asset and chief investment officer; and Glenn August, founder

    11/19/25 12:00:00 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Leadership Updates

    Live Leadership Updates

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    T. ROWE PRICE ANNOUNCES CREATION OF GLOBAL STRATEGY FUNCTION

    BALTIMORE, Nov. 13, 2025 /PRNewswire/ -- T. Rowe Price announced today the creation of a Global Strategy function to drive its strategic vision and elevate long-term planning. Andrew Reich will join the firm as head of Global Strategy on January 5, 2026. In this role, Reich will oversee the firm's corporate strategy, corporate development, mergers and acquisitions, and product development. Reich brings deep industry expertise, having most recently served as a partner and head of the Asset Management Practice for North America at McKinsey & Company. During his tenure, he helped

    11/13/25 8:15:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND AND ANNOUNCES ANNUAL MEETING VOTING RESULTS

    BALTIMORE, May 9, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.27 per share payable June 27, 2025, to stockholders of record as of the close of business on June 13, 2025. Additionally, at its annual meeting yesterday, T. Rowe Price Group, Inc.'s stockholders: Elected 11 directors to its Board of Directors;Approved, by a nonbinding advisory vote, the compensation paid by the Company to its Named Executive Officers;Ratified the appointment of KPMG LLP as the Company's indepen

    5/9/25 1:25:00 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Financials

    Live finance-specific insights

    View All

    T. ROWE PRICE GROUP REPORTS THIRD QUARTER 2025 RESULTS

    BALTIMORE, Oct. 31, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced its financial results for the third quarter of 2025. The earnings release can be found on the firm's website at troweprice.com/newsroom. Chair, Chief Executive Officer, and President Rob Sharps and Chief Financial Officer Jen Dardis will provide an update on business performance, review financial results, and answer questions on a webcast today from 8:00 - 8:45 AM ET. To access the webcast or to obtain dial-in instructions to ask a question, please visit investors.troweprice.com. Sup

    10/31/25 7:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND

    BALTIMORE, Oct. 28, 2025 /PRNewswire/ -- T. Rowe Price Group (NASDAQ-GS: TROW), a global asset management firm and a leader in retirement, announced today that its Board of Directors has declared a quarterly dividend of $1.27 per share payable on December 30, 2025, to stockholders of record as of the close of business on December 15, 2025. ABOUT T. ROWE PRICE T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm entrusted with managing $1.77 trillion in client assets as of September 30, 2025, about two-thirds of which are retirement-related. Renowned for ov

    10/28/25 12:20:00 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE GROUP DECLARES QUARTERLY DIVIDEND

    BALTIMORE, Nov. 1, 2024 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.24 per share payable December 27, 2024, to stockholders of record as of the close of business on December 13, 2024. ABOUT T. ROWE PRICEFounded in 1937, T. Rowe Price (NASDAQ – GS: TROW) helps individuals and institutions around the world achieve their long-term investment goals. As a large global asset management company known for investment excellence, retirement leadership, and independent proprietary research, the firm is built on a culture of integrity that puts client interests first. Clients rely on the award-winning f

    11/1/24 2:35:00 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

    SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    2/13/24 4:55:53 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

    SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    1/29/24 12:09:07 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

    SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    2/10/23 12:26:32 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance